
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $15.7B | -- | -- | $1.02 | -- |
07/31/2025 | Q2 | $15.3B | -- | -- | $0.95 | -- |
05/08/2025 | Q1 | $13.8B | $13.6B | $1.08 | $0.73 | $0.35 |
02/26/2025 | Q4 | $14.1B | $14.8B | $0.61 | $0.63 | -$0.02 |
10/31/2024 | Q3 | $15.7B | $15B | $1.03 | $0.91 | $0.12 |
08/01/2024 | Q2 | $15.3B | $15.3B | $0.73 | $0.85 | -$0.12 |
05/08/2024 | Q1 | $14.4B | $14.5B | $0.54 | $0.66 | -$0.12 |
02/29/2024 | Q4 | $15.6B | $14.5B | $0.94 | $0.71 | $0.23 |
10/31/2023 | Q3 | -- | -- | $0.73 | $0.81 | -$0.08 |
08/03/2023 | Q2 | -- | -- | $0.17 | $0.69 | -$0.52 |
05/04/2023 | Q1 | -- | -- | $0.81 | $0.62 | $0.19 |
03/02/2023 | Q4 | -- | -- | $1.41 | $0.71 | $0.70 |
10/27/2022 | Q3 | -- | -- | $0.71 | $0.73 | -$0.02 |
07/28/2022 | Q2 | -- | -- | $0.79 | $0.72 | $0.07 |
05/05/2022 | Q1 | -- | -- | $0.05 | $0.60 | -$0.55 |
02/24/2022 | Q4 | -- | -- | $0.98 | $0.77 | $0.21 |
10/28/2021 | Q3 | -- | -- | $0.12 | $0.55 | -$0.43 |
07/29/2021 | Q2 | -- | -- | $0.94 | $0.91 | $0.03 |
05/06/2021 | Q1 | -- | -- | $0.30 | $0.52 | -$0.22 |
02/25/2021 | Q4 | -- | -- | $1.13 | $0.93 | $0.21 |
10/23/2020 | Q3 | -- | -- | $0.52 | $0.70 | -$0.18 |
07/30/2020 | Q2 | -- | -- | $0.18 | $0.28 | -$0.10 |
05/07/2020 | Q1 | -- | -- | -$1.15 | -$0.49 | -$0.66 |
02/27/2020 | Q4 | -- | -- | $0.06 | $0.62 | -$0.56 |
10/25/2019 | Q3 | -- | -- | $1.51 | $1.17 | $0.34 |
07/25/2019 | Q2 | -- | -- | $1.26 | $1.15 | $0.11 |
05/07/2019 | Q1 | -- | -- | $1.80 | $1.14 | $0.66 |
02/28/2019 | Q4 | -- | -- | $0.23 | $0.93 | -$0.70 |
10/25/2018 | Q3 | -- | -- | $0.49 | $1.15 | -$0.66 |
07/26/2018 | Q2 | -- | -- | $0.98 | -- | -- |
05/09/2018 | Q1 | -- | -- | $0.52 | -- | -- |
03/01/2018 | Q4 | -- | -- | -- | -- | -- |
10/26/2017 | Q3 | -- | -- | $1.04 | -- | -- |
07/27/2017 | Q2 | -- | -- | $0.77 | -- | -- |
05/04/2017 | Q1 | -- | -- | $0.71 | -- | -- |
03/02/2017 | Q4 | -- | -- | $0.21 | -- | -- |
10/28/2016 | Q3 | -- | -- | $0.34 | -- | -- |
07/29/2016 | Q2 | -- | -- | $0.09 | -- | -- |
05/04/2016 | Q1 | -- | -- | $0.08 | -- | -- |
02/25/2016 | Q4 | -- | -- | $1.40 | -- | -- |
10/30/2015 | Q3 | -- | -- | $0.84 | -- | -- |
Anheuser-Busch InBev SA/NV reported $13.6B worth of top line sales in its most recent quarter.
Anheuser-Busch InBev SA/NV announced earnings per share of $1.08 which represents a beat of analyst forecast a $0.73 per share.
Anheuser-Busch InBev SA/NV reported $7.6B that represents $3.80 per share over the last quarter.
Anheuser-Busch InBev SA/NV's earnings are forecast to grow from $2.86 per share to $3.33 per share next year representing an increase of 32.61%.
Anheuser-Busch InBev SA/NV's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.